- Home
- Products & Services
ProfitGuard
Group purchasing and wholesaler contract negotiation service with business intelligence tools.
BuyLineA no-contract online pharmaceutical ordering service with competitive pricing and loyalty rewards points.
- About
- Elements
- News
- Resources
- Contact
Top Drug Patent Losses in 2018
January 24, 2018
PBA Health has compiled a list of the top drug patent losses slated to take effect during 2018. These brand patent expirations would open the door for generic versions of these products to launch.
“All generic launches are estimates and are contingent upon approval from the Food and Drug Administration (FDA),” said Mark Waltrip, Manager of Trade Relations at PBA Health.
Check back here for updates about new products in the PBA Health warehouse, including brands, generics and OTCs.
The following drugs have patents set to expire in 2018 and are organized by expiration date. (Adapted from this list on lowestmed.com.)
Here are the top drug patent losses expected in 2018
1. Follistim®
(Follitropin beta)
Patent Expiration Date: Jan. 14, 20182. Spiriva®
(Tiotropium)
Patent Expiration Date: Jan. 30, 20183. Makena®
(Hydroxyprogesterone)
Patent Expiration Date: Feb. 3, 20184. Astepro®
(Azelastine)
Patent Expiration Date: Feb. 20, 20185. Sensipar®
(Cinacalcet)
Patent Expiration Date: March 8, 20186. Adipra®
(Insulin glulisine)
Patent Expiration Date June 18, 20187. Lexiva®
(Fosamprenavir)
Patent Expiration Date: June 24, 20188. Tekturna®
(Sliskerin)
Patent Expiration Date: July 21, 20189. Tekturna® HCT
(Aliskren and hydrochlorothiazide tablets)
Patent Expiration Date: July 21, 201810. Tikosyn®
(Dofetilide)
Patent Expiration Date: Oct. 9, 201811. Promacta®
(Eltrombopag)
Patent Expiration Date: Oct. 30, 201812. Levitra®
(Vardenafil)
Patent Expiration Date: Oct. 31, 201813.Staxyn®
(Vardenafil)
Patent Expiration Date: Oct. 31, 201814. Fortesta®
(Testosterone)
Patent Expiration Date: Nov. 9, 201815. Symbicort®
(Budesonide/formoterol)
Patent Expiration Date: Nov. 11, 201816. Tyvaso®
(Treprostinil)
Patent Expiration Date: Nov. 13, 201817. Finacea®
(Azelaic acid)
Patent Expiration Date: Nov. 18, 201818. VESIcare®
(Solifenacin)
Patent Expiration Date: Nov. 19, 201819. Pradaxa®
(Dabigatran)
Patent Expiration Date: Nov. 20, 2018Related
© 2019 PBA Health. All rights reserved.
MENU